![Eric Lefebvre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 198 173 $ as of 2026-06-29
Eric Lefebvre currently works at Fonds D Investissement De La Culture Et Des Communications, LP, as Board of Director, The CIHR Canadian HIV Trials Network, as Member, and Canadian Association For HIV Research, as Member.
Dr. Lefebvre also formerly worked at GlaxoSmithKline, Inc., as Director-Medical Affairs from 2001 to 2003, CymaBay Therapeutics, Inc., as Independent Director from 2022 to 2024, Janssen Pharmaceuticals, Inc., as Head-Global Medical Affairs from 2003 to 2007, Tobira Therapeutics, Inc., as Chief Medical Officer, Allergan UC, as Vice President-Research & Development from 2016 to 2018, GlaxoSmithKline Pharmaceuticals SA (Belgium), as Principal, Tobira Therapeutics, Inc., as Chief Medical Officer from 2012 to 2016, and Pliant Therapeutics, Inc., as Chief Medical Officer from 2018 to 2025.
Dr. Lefebvre received his doctorate degree from the University of Montréal and undergraduate degree from College d'Enseignement General et Prof.
Edouard-Montpetit.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-14 | 173,836 ( 0.28% ) | 198 173 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
The CIHR Canadian HIV Trials Network
 The CIHR Canadian HIV Trials Network Miscellaneous Commercial ServicesCommercial Services Develops treatments, preventions, and cure for HIV and related health conditions | Corporate Officer/Principal | - |
Canadian Association For HIV Research | Corporate Officer/Principal | - |
Fonds D Investissement De La Culture Et Des Communications, LP
 Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance FICC invests in companies located in Quebec and Canada. The firm focuses on sectors of culture, communications and digital. It participates in early stage capital financing. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-12-14 |
| CYMABAY THERAPEUTICS, INC. | Director/Board Member | 2024-03-21 |
| ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 2018-03-31 |
| TOBIRA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2016-10-31 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
College d'Enseignement General et Prof. Edouard-Montpetit
 College d'Enseignement General et Prof. Edouard-Montpetit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance FICC invests in companies located in Quebec and Canada. The firm focuses on sectors of culture, communications and digital. It participates in early stage capital financing. | Finance |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
The CIHR Canadian HIV Trials Network
The CIHR Canadian HIV Trials Network Miscellaneous Commercial ServicesCommercial Services Develops treatments, preventions, and cure for HIV and related health conditions | Commercial Services |
Canadian Association For HIV Research |
Select your edition
All financial news and data tailored to specific country editions
